Assessment of lupus: where are we now?

Decisions about treatment for patients with SLE are based on numerous criteria, including the rate of change of clinical features and disease markers (especially antibodies to dsDNA and markers of complement turnover), which organ systems are affected, the severity of manifestations, and the presenc...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Ann Rheum Dis
Hauptverfasser:	Hay, E, Gordon, C, Emery, P
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMJ Publishing Group 1993
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1005009/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8484667/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.52.3.169
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!